1. Home
  2. PPBT vs GCTK Comparison

PPBT vs GCTK Comparison

Compare PPBT & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • GCTK
  • Stock Information
  • Founded
  • PPBT 2010
  • GCTK 2001
  • Country
  • PPBT Israel
  • GCTK United States
  • Employees
  • PPBT N/A
  • GCTK N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • GCTK Medical/Dental Instruments
  • Sector
  • PPBT Health Care
  • GCTK Health Care
  • Exchange
  • PPBT Nasdaq
  • GCTK Nasdaq
  • Market Cap
  • PPBT 9.2M
  • GCTK 7.6M
  • IPO Year
  • PPBT N/A
  • GCTK N/A
  • Fundamental
  • Price
  • PPBT $2.51
  • GCTK $0.27
  • Analyst Decision
  • PPBT Strong Buy
  • GCTK
  • Analyst Count
  • PPBT 2
  • GCTK 0
  • Target Price
  • PPBT $126.50
  • GCTK N/A
  • AVG Volume (30 Days)
  • PPBT 61.9K
  • GCTK 676.0K
  • Earning Date
  • PPBT 11-15-2024
  • GCTK 11-26-2024
  • Dividend Yield
  • PPBT N/A
  • GCTK N/A
  • EPS Growth
  • PPBT N/A
  • GCTK N/A
  • EPS
  • PPBT N/A
  • GCTK N/A
  • Revenue
  • PPBT N/A
  • GCTK N/A
  • Revenue This Year
  • PPBT N/A
  • GCTK N/A
  • Revenue Next Year
  • PPBT N/A
  • GCTK N/A
  • P/E Ratio
  • PPBT N/A
  • GCTK N/A
  • Revenue Growth
  • PPBT N/A
  • GCTK N/A
  • 52 Week Low
  • PPBT $2.43
  • GCTK $0.25
  • 52 Week High
  • PPBT $23.20
  • GCTK $4.95
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 28.04
  • GCTK 21.06
  • Support Level
  • PPBT $2.50
  • GCTK $1.20
  • Resistance Level
  • PPBT $2.82
  • GCTK $1.79
  • Average True Range (ATR)
  • PPBT 0.38
  • GCTK 0.30
  • MACD
  • PPBT 0.04
  • GCTK -0.12
  • Stochastic Oscillator
  • PPBT 5.10
  • GCTK 0.85

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

Share on Social Networks: